P95--LINKING DSB REPAIR AND CELL CYCLE CHECKPOINTS
P95——连接 DSB 修复和细胞周期检查点
基本信息
- 批准号:6386489
- 负责人:
- 金额:$ 17.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2002-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Nijmegen Breakage Syndrome (NBS) is an autosomal recessive disorder characterized by marked cancer predisposition, sensitivity to ionizing radiation, and defects in DNA damage dependent cell cycle checkpoints. Because the cellular phenotypes of NBS strongly resemble those of cells established from ataxia telangiectasia (AT) patients, this syndrome has been described as an AT variant syndrome although it is genetically distinct. We showed that NBS is attributable to deficiency in an intrinsic member of the hMre11/hRad50 protein complex, referred to herein as p95. We have established that this complex, which is uniformly distributed in the nucleus prior to irradiation, relocalizes to sites of DNA damage in the nuclei of cells treated with ionizing radiation, and is restored to uniform distribution upon completion of DNA repair. The association of the complex with DNA damage, in conjunction with the finding that cellular responses to ionizing radiation are abrogated by p95 deficiency lead to the hypothesis that the complex acts to sense and signal the presence of DNA damage in irradiated cells. In this proposal, we will examine the function of p95 to address this hypothesis, and to elucidate its potential role the repair of ionizing radiation-induced DNA damage as part of the Mre11/Rad50 complex. We propose to carry out phenotypic analyses of p95 deficient cells expressing variants of p95 to define functionally important domains of the protein. To examine phenotypes that are not assayable in cultured cells and to assess genetic interactions of p95, p95 deficient mice will be constructed. Of particular interest in this regard are the genetic and functional interactions between p95 and ATM which will be assessed by breeding of p95 and ATM deficient mice. These studies will provide important information regarding the relative contributions of p95 and ATM in the cellular and organismal responses to ionizing radiation. In this proposal, p95 is examined from three complementary perspectives. First, at the cellular level, second, at the molecular level, and third, in vivo through the derivation of a munbs1 mutant mouse.
奈梅亨断裂综合征 (NBS) 是一种常染色体隐性遗传疾病,其特征是显着的癌症倾向、对电离辐射的敏感性以及 DNA 损伤依赖性细胞周期检查点的缺陷。 由于 NBS 的细胞表型与共济失调性毛细血管扩张 (AT) 患者建立的细胞表型非常相似,因此这种综合征被描述为 AT 变异综合征,尽管它在遗传上是不同的。 我们证明NBS可归因于hMre11/hRad50蛋白复合物的内在成员(本文称为p95)的缺陷。 我们已经确定,这种复合物在辐射前均匀分布在细胞核中,重新定位到经电离辐射处理的细胞核中 DNA 损伤的位点,并在 DNA 修复完成后恢复到均匀分布。 该复合物与 DNA 损伤的关联,再加上 p95 缺陷会消除细胞对电离辐射的反应的发现,导致了这样的假设:该复合物的作用是感知并发出信号,表明受辐射细胞中存在 DNA 损伤。在本提案中,我们将检查 p95 的功能来解决这一假设,并阐明其作为 Mre11/Rad50 复合物的一部分修复电离辐射诱导的 DNA 损伤的潜在作用。 我们建议对表达 p95 变体的 p95 缺陷细胞进行表型分析,以确定该蛋白质的功能重要结构域。 为了检查在培养细胞中无法检测的表型并评估 p95 的遗传相互作用,将构建 p95 缺陷小鼠。 在这方面特别令人感兴趣的是 p95 和 ATM 之间的遗传和功能相互作用,将通过培育 p95 和 ATM 缺陷小鼠来评估。这些研究将提供有关 p95 和 ATM 在细胞和有机体对电离辐射反应中的相对贡献的重要信息。 在此提案中,从三个互补的角度对 p95 进行了审查。 首先,在细胞水平上,第二,在分子水平上,第三,通过munbs1突变小鼠的衍生在体内进行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John HJ Petrini其他文献
John HJ Petrini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John HJ Petrini', 18)}}的其他基金
FASEB SRC on Genetic Recombination and Genome Rearrangements
FASEB SRC 关于基因重组和基因组重排
- 批准号:
8199893 - 财政年份:2011
- 资助金额:
$ 17.46万 - 项目类别:
Project 3: Oncogene Activation and DNA Damage Response-Mediated Epigenetic Changes
项目3:癌基因激活和DNA损伤反应介导的表观遗传变化
- 批准号:
10132252 - 财政年份:2000
- 资助金额:
$ 17.46万 - 项目类别:
P95--LINKING DSB REPAIR AND CELL CYCLE CHECKPOINTS
P95——连接 DSB 修复和细胞周期检查点
- 批准号:
6182188 - 财政年份:1999
- 资助金额:
$ 17.46万 - 项目类别:
Regulation of the DNA damage response by the Mre11 complex
Mre11 复合物对 DNA 损伤反应的调节
- 批准号:
7737365 - 财政年份:1999
- 资助金额:
$ 17.46万 - 项目类别:
Regulation of the DNA damage response by the Mre11 complex
Mre11 复合物对 DNA 损伤反应的调节
- 批准号:
8415942 - 财政年份:1999
- 资助金额:
$ 17.46万 - 项目类别:
Regulation of the DNA damage response by the Mre11 complex
Mre11 复合物对 DNA 损伤反应的调节
- 批准号:
7535601 - 财政年份:1999
- 资助金额:
$ 17.46万 - 项目类别:
相似海外基金
DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
- 批准号:
10748479 - 财政年份:2024
- 资助金额:
$ 17.46万 - 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
- 批准号:
2338236 - 财政年份:2024
- 资助金额:
$ 17.46万 - 项目类别:
Continuing Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
- 批准号:
23K07078 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
- 批准号:
10550045 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
- 批准号:
23H05475 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
- 批准号:
2246561 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Standard Grant
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
- 批准号:
10666307 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
- 批准号:
10651048 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
- 批准号:
10734425 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:














{{item.name}}会员




